Aciclovir Market will Reach US$ 4.82 Billion by 2034 Amid Growing Viral Infection Cases
The Aciclovir Market is experiencing significant growth due to the increasing prevalence of viral infections, expanding access to antiviral therapies, and continuous advancements in pharmaceutical manufacturing. Aciclovir remains one of the most widely prescribed antiviral medications for treating herpes simplex …